Clinical and silent stroke following aortic valve surgery and transcatheter aortic valve implantation

Cardiovascular Revascularization Medicine

Volumn 13, Issue 2, 2012, Pages 133-140

  Hauville, Camille ^a   Ben Dor, Itsik ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Aortic valve replacement; Silent and clinical strokes; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE REPLACEMENT; BRAIN EMBOLISM; BRAIN INJURY; DEVICE THERAPY; EMBOLIC PROTECTION DEVICE; HUMAN; INCIDENCE; MENTAL DETERIORATION; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STROKE; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RISK ASSESSMENT; RISK FACTORS; STROKE; SURVIVAL RATE; WORLD HEALTH;

EID: 84859649535     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2011.11.001     Document Type: Review

References (52)

1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630-634.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118 2008, e523-661. 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force.
3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008.
4. Dvir D, Assali A, Sagie A, Porat E, Shapira Y, Vaknin H, Bobovnikov V, Shafir G, Kupershmidt M, Shor N, Battler A, Kornowski R Severe aortic stenosis patients at high surgical risk: outcomes according to treatment assignment. Cardiovasc Revasc Med 2011, e27:12.
5. Pasic M, Unbehaun A, Buz S, Drews T, Dreysse S, Kukucka M, Mladenow A, Hetzer R Transapical aortic valve implantation: first 325 patients in a single center. Cardiovasc Revasc Med 2011, 12:e26-27.
6. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.
7. Martin WR, Hashimoto SA Stroke in coronary bypass surgery. Can J Neurol Sci 1982, 9:21-26.
8. Coffey CE, Massey EW, Roberts KB, Curtis S, Jones RH, Pryor DB Natural history of cerebral complications of coronary artery bypass graft surgery. Neurology 1983, 33:1416-1421.
9. Breuer AC, Furlan AJ, Hanson MR, Lederman RJ, Loop FD, Cosgrove DM, Greenstreet RL, Estafanous FG Central nervous system complications of coronary artery bypass graft surgery: prospective analysis of 421 patients. Stroke 1983, 14:682-687.
10. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996, 335:1857-1863.
11. Bucerius J, Gummert JF, Borger MA, Walther T, Doll N, Onnasch JF, Metz S, Falk V, Mohr FW Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003, 75:472-478.
12. Bakaeen FG, Chu D, Huh J, Carabello BA Is an age of 80 years or greater an important predictor of short-term outcomes of isolated aortic valve replacement in veterans?. Ann Thorac Surg 2010, 90:769-774.
13. Filsoufi F, Rahmanian PB, Castillo JG, Bronster D, Adams DH Incidence, imaging analysis, and early and late outcomes of stroke after cardiac valve operation. Am J Cardiol 2008, 101:1472-1478.
14. Gulbins H, Florath I, Ennker J Cerebrovascular events after stentless aortic valve replacement during a 9-year follow-up period. Ann Thorac Surg 2008, 86:769-773.
15. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009, 137:82-90.
16. Floyd TF, Shah PN, Price CC, Harris F, Ratcliffe SJ, Acker MA, Bavaria JE, Rahmouni H, Kuersten B, Wiegers S, McGarvey ML, Woo JY, Pochettino AA, Melhem ER Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg 2006, 81:2160-2166.
17. Gass A, Ay H, Szabo K, Koroshetz WJ Diffusion-weighted MRI for the "small stuff": the details of acute cerebral ischaemia. Lancet Neurol 2004, 3:39-45.
18. Stolz E, Gerriets T, Kluge A, Klövekorn WP, Kaps M, Bachmann G Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement: implications for future neuroprotective trials?. Stroke 2004, 35:888-892.
19. Bendszus M, Stoll G Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006, 5:364-372.
20. Selnes OA, Goldsborough MA, Borowicz LM, McKhann GM Neurobehavioural sequelae of cardiopulmonary bypass. Lancet 1999, 353:1601-1606.
21. Knipp SC, Matatko N, Schlamann M, Wilhelm H, Thielmann M, Forsting M, Diener HC, Jakob H Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005, 28:88-96.
22. Gerriets T, Schwarz N, Bachmann G, Kaps M, Kloevekorn WP, Sammer G, Tschernatsch M, Nottbohm R, Blaes F, Schönburg M Evaluation of methods to predict early long-term neurobehavioral outcome after coronary artery bypass grafting. Am J Cardiol 2010, 105:1095-1101.
23. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011, 32:205-217.
24. King A Valvular disease: PARTNER cohort A-TAVR is an option for operable severe aortic stenosis. Nat Rev Cardiolf 2011, 8:422.
25. Kempfert J, Van Linden A, Linke A, Schuler G, Rastan A, Lehmann S, Lehmkuhl L, Mohr FW, Walther T Transapical aortic valve implantation: therapy of choice for patients with aortic stenosis and porcelain aorta?. Ann Thorac Surg 2010, 90:1457-1461.
26. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Détaint D, Brochet E, Messika-Zeitoun D, Francis F, Ibrahim H, Nataf P, Vahanian A Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009, 54:303-311.
27. Bleiziffer S, Ruge H, Mazzitelli D, Hutter A, Opitz A, Bauernschmitt R, Lange R Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg 2009, 138:1073-1080.
28. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, CÔté M, Pibarot P, Webb JG Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011, 57:18-28.
29. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010, 55:1427-1432.
30. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010, 121:870-878.
31. Arnold M, Schulz-Heise S, Achenbach S, Ott S, Dörfler A, Ropers D, Feyrer R, Einhaus F, Loders S, Mahmoud F, Roerick O, Daniel WG, Weyand M, Ensminger SM, Ludwig J Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv 2010, 3:1126-1132.
32. Wityk RJ, Goldsborough MA, Hillis A, Beauchamp N, Barker PB, Borowicz LM, McKhann GM Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol 2001, 58:571-576.
33. Román GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, López-Pousa S, Arizaga R, Wallin A Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004, 226:81-87.
34. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001, 344:395-402. Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators.
35. Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, Blackman DJ, Plein S, Greenwood JP Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2011, [epub ahead of print].
36. Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Lüderitz B, Schild H, Sommer T Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003, 361:1241-1246.
37. Barbut D, Hinton RB, Szatrowski TP, Hartman GS, Bruefach M, Williams-Russo P, Charlson ME, Gold JP Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke 1994, 25:2398-2402.
38. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994, 25:1393-1399.
39. Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS Brain microemboli during cardiac surgery or aortography. Ann Neurol 1990, 28:477-486.
40. Brown WR, Moody DM, Challa VR, Stump DA, Hammon JW Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke 2000, 31:707-713.
41. Wolman RL, Nussmeier NA, Aggarwal A, Kanchuger MS, Roach GW, Newman MF, Mangano CM, Marschall KE, Ley C, Boisvert DM, Ozanne GM, Herskowitz A, Graham SH, Mangano DT Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators. Stroke 1999, 30:514-522.
42. Blauth CI Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg 1995, 59:1300-1303.
43. Harris DN, Bailey SM, Smith PL, Taylor KM, Oatridge A, Bydder GM Brain swelling in first hour after coronary artery bypass surgery. Lancet 1993, 342:586-587.
44. Caplan LR, Hennerici M Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998, 55:1475-1482.
45. Lund C, Sundet K, Tennøe B, Hol PK, Rein KA, Fosse E, Russell D Cerebral ischemic injury and cognitive impairment after off-pump and on-pump coronary artery bypass grafting surgery. Ann Thorac Surg 2005, 80:2126-2131.
46. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010, 122:62-69.
47. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080-1090.
48. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P, FRANCE Registry Investigators Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011, 32:191-197.
49. Carpenter JP, Carpenter JT, Tellez A, Webb JG, Yi GH, Granada JF A percutaneous aortic device for cerebral embolic protection during cardiovascular intervention. J Vasc Surg 2011, 54:174-181.
50. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D, Fehske W, Wolner E, Mohr FW, Mack M Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007, 116(11 Suppl):I240-245.
51. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69-76.
52. Walther T, Kasimir MT, Doss M, Schuler G, Simon P, Schächinger V, Mohr FW, Wimmer-Greinecker G One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2011, 39:532-537.